EYFLIQ

Serial Number 97127069
734

Registration Progress

Application Filed
Nov 16, 2021
Under Examination
Nov 8, 2022
Approved for Publication
Sep 13, 2022
Published for Opposition
Sep 13, 2022
Registered

Attorney Assistance

Statement of Use Due - Extension 5 Granted
Due: Nov 08, 2025 113 days
Statement of Use required (all extensions used)

Trademark Image

EYFLIQ

Basic Information

Serial Number
97127069
Filing Date
November 16, 2021
Published for Opposition
September 13, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
734
Status Date
May 8, 2025
Application
Pending
Classes
005

Rights Holder

Sun Pharma Advanced Research Company Limited

16
Address
17/B, Mahal Industrial Estate
Mahakali Caves Road, Andheri (East)
Mumbai 400093
IN

Ownership History

Sun Pharma Advanced Research Company Limited

Original Applicant
16
Mumbai IN

Sun Pharma Advanced Research Company Limited

Owner at Publication
16
Mumbai IN

Legal Representation

Attorney
Craig Kuchii

USPTO Deadlines

Next Deadline
113 days remaining
Statement of Use Due - Extension 5 Granted
Due Date
November 08, 2025

Application History

29 events
Date Code Type Description Documents
May 8, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 8, 2025 EX5G S SOU EXTENSION 5 GRANTED Loading...
May 6, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 6, 2025 EXT5 S SOU EXTENSION 5 FILED Loading...
Dec 2, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 2, 2024 EX4G S SOU EXTENSION 4 GRANTED Loading...
Nov 29, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 8, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 8, 2024 EXT4 S SOU EXTENSION 4 FILED Loading...
May 8, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 7, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
May 7, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 7, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Nov 10, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 8, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Nov 8, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Nov 8, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 9, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 5, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 5, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
May 5, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 8, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 13, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 13, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 24, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 9, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 9, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 22, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 19, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the treatment of ophthalmic diseases and disorders

Classification

International Classes
005